SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Sep 2, 2016
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: Sept. 2, 2016 · CIK: 0001174940 · Accession: 0001193125-16-700835
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-213321
Letter
VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission Washington, D.C. 20549-3628 Re: Oragenics, Inc. (the “Company”) Registration Statement on Form S-3 File No. 333-213321
Dear Mr. McCann:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated so that it will be declared effective at 4:00 p.m., Eastern Daylight Time, on Wednesday, September 7, 2016, or as soon thereafter as is practicable.
The Company hereby acknowledges that:
•
should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We hereby authorize Mark A. Catchur of Shumaker, Loop & Kendrick, LLP, our outside legal counsel, to orally modify or withdraw this request of acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Catchur at (813) 227-2264. Thank you for your assistance in this matter.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Oragenics, Inc. 4902 Eisenhower Boulevard, Suite Tampa, Florida 33634 September 2, 2016 VIA EDGAR Joseph McCann Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 Re: Oragenics, Inc. (the “Company”) Registration Statement on Form S-3 File No. 333-213321 Dear Mr. McCann: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated so that it will be declared effective at 4:00 p.m., Eastern Daylight Time, on Wednesday, September 7, 2016, or as soon thereafter as is practicable. The Company hereby acknowledges that: • should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We hereby authorize Mark A. Catchur of Shumaker, Loop & Kendrick, LLP, our outside legal counsel, to orally modify or withdraw this request of acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Catchur at (813) 227-2264. Thank you for your assistance in this matter. Very truly yours, By: /s/ Michael Sullivan Name: Michael Sullivan Title: Chief Financial Officer cc: Mark A. Catchur, Shumaker, Loop & Kendrick, LLP